Reduction in new-onset diabetes mellitus after renal transplant with erythropoietin-stimulating agents: a retrospective cohort study
Conclusion
ESA exposure may be associated with a reduced incidence of NODAT in the post-renal transplant population. The role of ESA in preventing NODAT requires further investigation.
Source: Canadian Journal of Kidney Health and Disease - Category: Urology & Nephrology Source Type: research
More News: Bone Graft | Diabetes | Diabetes Mellitus | Endocrinology | Health | Kidney Transplant | Kidney Transplantation | Pancreas | Study | Transplant Surgery | Transplants | Urology & Nephrology